Benralizumab Outcomes in Patients with Severe Eosinophilic Asthma Treated in Real-Life Settings: Results of the BREEZE Study in 5 Countries From Central Eastern Europe and Baltics

Benralizumab Outcomes in Patients with Severe Eosinophilic Asthma Treated in Real-Life Settings: Results of the BREEZE Study in 5 Countries From Central Eastern Europe and Baltics

Florin Mihaltan,1 Zsuzsanna Csoma,2 Norbert Pauk,3 Béla Irás,4 Jūratė Baukienė,5 Gabriela Teodorescu,6 Kęstutis Malakauskas,7 Maria Staevska8 1Department of Pneumology, University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania; 2Department of Allerg...

Full description

Saved in:
Bibliographic Details
Main Authors: Mihaltan F, Csoma Z, Pauk N, Irás B, Baukienė J, Teodorescu G, Malakauskas K, Staevska M
Format: Article
Language:English
Published: Dove Medical Press 2025-02-01
Series:Journal of Asthma and Allergy
Subjects:
real-world
biological therapy
exacerbation rate
eosinophils
maintenance oral corticosteroids
asthma control.
Online Access:https://www.dovepress.com/benralizumab-outcomes-in-patients-with-severe-eosinophilic-asthma-trea-peer-reviewed-fulltext-article-JAA
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/benralizumab-outcomes-in-patients-with-severe-eosinophilic-asthma-trea-peer-reviewed-fulltext-article-JAA

Similar Items